Introduction
============

Breast cancer is one of the most common malignant diseases and poses significant morbidity and mortality to women worldwide. As the study of breast cancer has progressed and the biological behaviors of tumors are starting to be elucidated, increasing evidence has suggested that breast cancer is a systemic disease. This is in opposition to the traditional view, which suggested that the disease only occurred in the breast ([@b1-ol-0-0-11501]--[@b4-ol-0-0-11501]).

Treatment strategies for breast cancer have been gradually moving toward a systemic approach. Breast-conserving surgery together with post-operative radiotherapy and chemotherapy do not increase the risk of recurrence, and even if there are one or two positive sentinel lymph nodes, comprehensive treatment after surgery can result in similar effects to those of traditional radical surgery ([@b5-ol-0-0-11501]). The surgical treatment of breast cancer has vastly improved in recent years, and is becoming more precise and with improved cosmetic outcomes. Endoscopic techniques for breast surgery were first reported by Kompatscher ([@b6-ol-0-0-11501]), who removed breast contracture implants under endoscopy. Since then, endoscopic techniques have been applied to other surgeries. In 1994, Fine *et al* ([@b7-ol-0-0-11501]) reported endoscopic-assisted muscle flap harvest to guide abdominal visceral surgery. The first endoscopic surgery for the treatment of breast cancer was reported by Salvat *et al* ([@b8-ol-0-0-11501]), who performed an endoscopic axillary lymph node dissection (ALND). In 2000, endoscopic sentinel node detection in patients with breast cancer patients was documented by Kühn *et al* ([@b9-ol-0-0-11501]). Therefore, endoscopic techniques have been used in benign and malignant breast disease treatment.

Mastoscopic axillary lymph node dissection (MALND) has become one of the most important methods for the treatment of breast cancer. MALND results in less trauma and blood loss, fewer post-operative complications and faster post-operative recovery ([@b10-ol-0-0-11501]). However, the breast is a solid organ with no natural lumen. Furthermore, the abundant fat and gland increase make this procedure challenging and have limited the wider development of endoscopic techniques in the surgical treatment of breast cancer. The most widely used mastoscopic technique is the lipolysis method which has been mostly performed on patients with limited breast tissue and mostly Asian women. In 1998, Brun *et al* ([@b11-ol-0-0-11501]) reported fat and lymph node suction in breast cancer axillary lymphadenectomy. Luo *et al* ([@b10-ol-0-0-11501]) also shared their abundant experience on lipolytic endoscopic axillary surgery. Although certain reports indicate that lipolysis does not increase the risk of recurrence of breast cancer and does not reduce the overall survival of patients, liposuction may destroy, not only the whole tumor, but also the lymph nodes, thereby increasing the risk of local and distant metastases ([@b12-ol-0-0-11501]). Therefore, lipolytic therapy is not a popular treatment method for breast cancer. Endoscopic axillary lymphadenectomy without prior liposuction was reported in 1999 ([@b13-ol-0-0-11501]). This therapeutic approach has not been comprehensively used for wounds close to the armpits and does not result in improved outcomes compared with traditional small-incision-axillary surgery.

In order to overcome these flaws, the present study described a novel endoscopic axillary lymphadenectomy technique without prior liposuction and less visible scarring after surgery.

Patients and methods
====================

### Case selection

A total of 16 female patients with breast cancer who underwent MALND from 2016.01.12 to 2018.06.01 at the Second Affiliated Hospital of Fujian Medical University (Quanzhou, China) were selected. The mean age of the patients was 44.81 years (range, 27--58 years). Patients had masses 1.1--4.0 cm in diameter that were located in the upper outer quadrant of the breast. The patients had a mean body mass index (BMI) of 21.21 kg/m^2^ (range, 17.93--24.35 kg/m^2^). The BMI of the 16 patients is presented in [Table I](#tI-ol-0-0-11501){ref-type="table"}.

Breast cancer was diagnosed by core needle biopsy, and the relevant examination was completed prior to surgery. If the preoperative ultrasound suggested an axillary lymph node (ALN), fine needle aspiration was performed to determine whether a sentinel lymph node biopsy (SLNB) should be performed. The inclusion criteria for this study were as follows: Non-obese breast cancer patients, and patients with breast tumors not in the inward quadrant. The exclusion criteria for this study were: Obese breast cancer patients, breast cancer patients with tumors in the inner quadrant, and elderly patients with severe heart or lung disease. For the surgical procedure, periareolar incision on the quadrant ring was made as the main incision and the other 0.5 cm trocar incision was located on the anterior axillary line ([Fig. 1A](#f1-ol-0-0-11501){ref-type="fig"}).

The study was approved by the Ethics Committee of the Second Affiliated Hospital of Fujian Medical University (Quanzhou, China). Written informed consent was obtained from all patients.

### Resection of malignant tumor and margin of the breast

The patients were placed in a supine position with the ipsilateral arm at a 90° abduction under general anesthesia ([Fig. 1B](#f1-ol-0-0-11501){ref-type="fig"}). An endoscopic operating system (Storz HD Xenon Nova 300 system.) was used. The whole tumor was excised through a periareolar incision. During the process, safety margins were identified and a core needle biopsy puncture was used for resection. Cavity shaving was used to confirm that the margins were negative. A fast-frozen pathology report indicated that the margins were negative.

### Endoscopic surgery and tracer lymph nodes

Prior to endoscopy, two trocars (5 and 10 mm, respectively) were placed in the cavity through the periareolar incision. The wound between the two trocars was closed to ensure that the carbon dioxide did not leak out. A third trocar was placed in the cavity through the 0.5 cm incision located on the anterior axillary line. A 30° 10 mm endoscope was inserted through the 10 mm trocar, and carbon dioxide was infused into the cavity until \~8 mmHg pressure was reached ([Fig. 1C](#f1-ol-0-0-11501){ref-type="fig"}). The sentinel lymph node-labeled tracer (methylene blue dye double diluted with normal saline) was injected along the anterior axillary line close to the armpit to ensure that the dye did not leak into the cavity. The subcutaneous tissue was subsequently separated and sentinel lymph node progress was observed.

### SLNB

Tissues were separated along the pectoralis muscle to the axilla. Sentinel lymph nodes are often located outside the margin of the superficial layer of fascia coracocleidopectoralis of the pectoralis minor muscle. During this process, attention should be paid to finding blue-stained lymph nodes and lymphatic channels. After locating the blue-stained areas, the tissue was separated, but not removed, from the lymphatic tissue. A total of 2--3 lymph nodes were found ([Fig. 2A](#f2-ol-0-0-11501){ref-type="fig"}). The lymph nodes were subsequently resected and sent for further pathological examination. ALND should be performed when SLNB is not successful or pathological reports indicate cancer cells in the lymph nodes.

### ALND

The axillary vein was exposed by separating the pectoralis and the pectoralis minor muscles in the direction of the axilla. During this process, the axillary vein was used to indicate direction ([Fig. 2B](#f2-ol-0-0-11501){ref-type="fig"}). Next, the structure was separated as follows: Thoracodorsal vein and nerve, axillary vein and long thoracic nerve, as observed by mastoscopy ([Fig. 2C](#f2-ol-0-0-11501){ref-type="fig"}), other important structures and anatomical landmarks. Certain important structures, such as the medial pectoral nerve, were preserved if possible. Axillary level I and II lymph nodes were dissected. When visible lymph nodes appeared between the pectoralis major and minor, the lymph nodes between the pectoralis muscles were also resected. In the present study, two methods were used to create a good view of the back of the pectoral muscle. The first method was the rotation and displacement of the endoscope lens for a better exposure of the back of the pectoral muscle. The second method was the use a special V-shaped hook for a better exposure of the back of the pectoral muscle. The V-shaped hook ([Fig. 2D](#f2-ol-0-0-11501){ref-type="fig"}) is often used for endoscopic surgery of thyroid tumors. The axillary lymph tissue was removed. The axilla was washed with warm distilled water, and drained using a suction tube placed in the inferior trocar hole. Lastly, the chest and axilla were bandaged.

Results
=======

### Post-surgical results

The post-surgical results are evident in [Figs. 2C](#f2-ol-0-0-11501){ref-type="fig"} and [3](#f3-ol-0-0-11501){ref-type="fig"}. [Fig. 2C](#f2-ol-0-0-11501){ref-type="fig"} presents the overview following surgery. The thoracodorsal vein and nerve, axillary vein and long thoracic nerve are clearly seen. [Fig. 3A and B](#f3-ol-0-0-11501){ref-type="fig"} show the pre- and post-operative breast, respectively.

### Patient characteristics and MALND

A total of 16 cases of MALND were examined between 2016.01.12 and 2018.06.01. The statistical results are presented in [Tables II](#tII-ol-0-0-11501){ref-type="table"} and [III](#tIII-ol-0-0-11501){ref-type="table"}. The patients\' average age was 44.81±6.82 years, the average tumor diameter was 2.43±0.82 cm and the average BMI was 21.21±1.66 kg/m^2^. A total of 4 patients received SLNB, 7 received ALND and 5 received both. The mean operation time of SLNB was 35.11±3.82 min and that of ALND was 51.08±5.92 min. The mean intraoperative blood loss was 29.25±8.93 ml and the volume of drainage of SLNB and ALND was 63.25±6.36 and 148.42±21.18 ml, respectively. The average duration of drainage was 6.56±1.50 days. The mean follow-up period was \~28 months (range, 12--41 months). One of the 16 patients presented paresthesia in the medial upper arm, which decreased or disappeared 3 months after the operation. One patient developed mild edema in the upper arm 3 months after the operation, which decreased following treatment with elastic bandage compression, local massage and functional exercise to promote lymphatic reflux. The other patients exhibited no wound effusion, upper limb edema or flap necrosis. Post-operative B-ultrasound and molybdenum target X-ray examination showed no tumor recurrence, and the motion of shoulder joint was good. A total of 30 sentinel lymph nodes were harvested from 9 patients, with a mean number of 3.33±0.50 sentinel lymph nodes per patient and a positive rate of 20%. A total of 189 ALNs were excised from 12 patients and the mean number of ALNs per patient was 15.75±2.67. The percentage of patients tested positive for ALNs was 18.52%. A pathology report revealed that 14 patients were diagnosed with invasive breast cancer, 1 with mucinous breast cancer and 1 with ductal carcinoma in situ. Histology also revealed 62.5, 12.5 and 25% positive rates for ER/PR(+), HER2(+) and triple negative breast cancer, respectively.

Discussion
==========

Endoscopic techniques have been used in breast surgery for several years. A number of mastoscopic therapeutic methods including benign tumor resection, SLNB, ALND and breast reconstruction have been previously reported ([@b6-ol-0-0-11501],[@b9-ol-0-0-11501],[@b14-ol-0-0-11501],[@b15-ol-0-0-11501]). Endoscopic methods are broadly divided into lipolytic and non-lipolytic methods, of which the former are more widely used. The majority of mastoscopic incisions are located in or next to the axilla ([@b9-ol-0-0-11501],[@b13-ol-0-0-11501],[@b16-ol-0-0-11501],[@b17-ol-0-0-11501]). A number of innovative cases have also been reported ([@b18-ol-0-0-11501]--[@b21-ol-0-0-11501]). However, mastoscopic surgery has several shortcomings. Lipolytic mastoscopy remains controversial and non-lipolytic therapy is challenging to perform. As normal ALND and SLNB can be performed with a small incision through the armpits, endoscopic incisions in this region offer no advantage with respect to appearance. The present study revealed that ALND can be achieved under mastoscopy with additional incisions, and can result in a cosmetically pleasing result. Furthermore, the operation time, intraoperative blood loss, drainage flow and direction of drainage have been reported to offer no disadvantage compared with traditional radical excision ([@b10-ol-0-0-11501],[@b12-ol-0-0-11501]). A retrospective study suggested that endoscopic axillary lymphadenectomy without liposuction does not increase the risk of complications and is safe to perform ([@b22-ol-0-0-11501]). In the present study, only two cases presented complications among the 16 cases of non-lipolytic endoscopic axillary surgery. The complications were paresthesia and upper limb edema, which were significantly improved following treatment. Therefore, MALND requires further investigation.

Breast-conserving surgery is gradually becoming the first choice for the treatment of breast cancer for several patients with clinical stage I and II cancer. In the field of breast surgery, safety, acceptable cosmetic outcome and minimal invasiveness are of paramount importance. Non-lipolytic mastoscopic SLNB is challenging to perform ([@b9-ol-0-0-11501],[@b23-ol-0-0-11501]) and the appearance of the affected area has not been satisfactory, as locating lymph nodes tracts is difficult even in open surgery. However, as sentinel lymph node dye continues to advance, locating sentinel lymph nodes under endoscopy may become less difficult. In the present study, methylene blue dye was used to locate sentinel lymph nodes. Experience suggests that the application of methylene blue dye is an examination technique worth using with mastoscopy. The present study also suggested that non-lipolytic mastoscopy may be performed without the need for an additional incision next to the armpits and can result in good outcomes following surgery.

However, non-lipolytic endoscopic axillary surgery also has shortcomings. Firstly, the operation is more difficult in obese patients and those with large breasts, and may not be suitable for patients with inner quadrant breast cancer. Secondly, the number of cases evaluated in the present study was limited and longer-term follow-up data are required. Thirdly, non-lipolytic endoscopic cavity mirror technology increases the difficulty of the surgery and the operation time, and requires expert surgeons. Prior to developing this therapy, 210 cases of endoscopic thyroid operation were performed in order to prepare for this technique ([@b24-ol-0-0-11501]).

The present study introduced a novel practice for breast-conserving surgery. SLNB and ALND may be performed without other incisions. Non-lipolytic mastoscopic axillary surgery may be a good choice for breast cancer therapy and may become part of the repertoire of breast cancer treatment strategies.
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![(A) A periareolar incision was marked, the tumor position was identified, and 0.5 cm trocar incision was marked on the anterior axillary line. (B) Patient in supine position with the ipsilateral arm at a 90° abduction. (C) Outside view of the operation with three trocars placed in the cavity.](ol-19-06-4088-g00){#f1-ol-0-0-11501}

![(A) A sentinel lymph node stained by blue dye was separated out under endoscopy. A lymph node duct was observed on the screen. (B) The axillary vein was exposed during the endoscopic procedure. (C) Important structures, such as thoracodorsal vein and nerve, axillary vein and long thoracic nerve, were observed under mastoscopy. (D) V-shaped hook was used for better exposure of the back of the pectoral muscle.](ol-19-06-4088-g01){#f2-ol-0-0-11501}

![(A) Preoperative and (B) post-operative image of the breast.](ol-19-06-4088-g02){#f3-ol-0-0-11501}

###### 

Patient characteristics.

  No.   Height (m)   Weight (kg)   BMI (kg/m^2^)
  ----- ------------ ------------- ---------------
  1     1.53         57            24.35
  2     1.59         59            23.34
  3     1.69         66            23.11
  4     1.59         57            22.55
  5     1.59         56            22.15
  6     1.6          55            21.48
  7     1.56         52            21.37
  8     1.61         55            21.22
  9     1.64         57            21.19
  10    1.64         56            20.82
  11    1.65         56            20.57
  12    1.56         50            20.55
  13    1.66         56            20.32
  14    1.62         51            19.43
  15    1.67         53            19.00
  16    1.67         50            17.93

BMI, body mass index.

###### 

Patient and tumor characteristics.

  Parameters                                                  Values
  ----------------------------------------------------------- --------------
  Age (years)                                                 
    Mean                                                      44.81±6.82
    Range                                                     27-58
  Tumor diameter (cm)                                         
    Mean                                                        2.43±0.82
    Range                                                     1.1--4.0
  BMI (kg/m^2^)                                               
    Mean                                                      21.21±1.66
    Range                                                     17.93--24.35
  T stage \[n (%)\]                                           
    T1                                                          6 (37.5)
    T2                                                          10 (62.5)
  SLNB and/or ALND \[n (%)\]                                  
    SLNB alone                                                4 (25)
    ALND alone                                                  7 (43.8)
    SLNB and ALND                                               5 (31.2)
  N stage \[n (%)\]                                           
    N0                                                        4 (25)
    N+                                                        12 (75)
  Quadrant \[n (%)\]                                          
    Upper outer                                               16 (100)
    Upper inter                                               0 (0)
    Lower outer                                               0 (0)
    Lower inter                                               0 (0)
    Areolar                                                   0 (0)
  Histological type                                           
    Invasive breast cancer                                    14
    Mucinous breast cancer                                    1
    Ductal carcinoma in situ                                  1
  Estrogen receptor status \[n (%)\]                          
    Positive                                                    10 (62.5)
    Negative                                                    6 (37.5)
  Progesterone receptor status \[n (%)\]                      
    Positive                                                    10 (62.5)
    Negative                                                    6 (37.5)
  Human epidermal growth factor receptor-2 status \[n (%)\]   
    Positive                                                    2 (12.5)
    Negative                                                    14 (87.5)

BMI, body mass index; SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection.

###### 

Clinical results of 16 patients.

  Parameters                            Values
  ------------------------------------- --------------
  Average operation time (min)          
    SLNB                                35.11±3.82
    ALND                                51.08±5.92
  Operative blood loss (ml)             29.25±8.93
  Volume of drainage (ml)               
    SLNB                                63.25±6.36
    ALND                                148.42±21.18
  Average duration of drainage (days)     6.56±1.50
  Complications                         
    Paresthesia (pain, numbness)        1
    Wound effusion                      0
    Upper limb edema                    1
    Flap necrosis                       0
    Local and distant recurrence        0
    Shoulder joint movement disorder    0
  Average number of lymph nodes         
    SLNs from 9 patients                  3.33±0.50
    ALNs from 12 patients               15.75±2.67

SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; SLNs, sentinel lymph nodes; ALNs, axillary lymph nodes.
